Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance-Reference-Cited by-同舟云学术

Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance

Published:2017-10-13 Issue:1 Volume:280 Page:165-174
ISSN:0105-2896
Container-title:Immunological Reviews
language:en
Short-container-title:Immunol Rev

Author:

Bloy Norma¹²³⁴⁵,Garcia Pauline³⁶⁷,Laumont Céline M.⁸⁹,Pitt Jonathan M.¹¹⁰¹¹,Sistigu Antonella¹²,Stoll Gautier¹²³⁴,Yamazaki Takahiro¹¹,Bonneil Eric⁸,Buqué Aitziber¹²³⁴⁶,Humeau Juliette¹²³⁴⁵,Drijfhout Jan W.¹³¹⁴,Meurice Guillaume¹⁵,Walter Steffen¹⁶,Fritsche Jens¹⁷,Weinschenk Toni¹⁶¹⁷,Rammensee Hans-Georg¹⁸,Melief Cornelis¹⁹,Thibault Pierre⁸²⁰,Perreault Claude⁸⁹²¹,Pol Jonathan¹²³⁴⁶,Zitvogel Laurence¹⁰¹¹¹⁰^ORCID,Senovilla Laura¹²³⁴,Kroemer Guido¹²³⁴²²^ORCID

Affiliation:

1. Sorbonne Paris Cité; Université Paris Descartes; Paris France

2. Equipe 11 labellisée Ligue Nationale contre le Cancer; Centre de Recherche des Cordeliers; Paris France

3. Institut National de la Santé et de la Recherche Médicale; U1138; Paris France

4. Université Pierre et Marie Curie; Paris France

5. Metabolomics and Cell Biology Platforms; Gustave Roussy Cancer Campus; Villejuif France. Institut Gustave Roussy Cancer Campus; Villejuif France. Faculty of Medicine; University of Paris Sud; Kremlin-Bicêtre France

6. Institut Gustave Roussy Cancer Campus; Villejuif France

7. Faculty of Medicine; University of Paris Sud; Kremlin-Bicêtre France

8. Institute for Research in Immunology and Cancer; Université de Montréal; Montreal Quebec Canada

9. Department of Medicine; Faculty of Medicine; Université de Montréal; Montreal Quebec Canada

10. Center of Clinical Investigations in Biotherapies of Cancer (CICBT); Villejuif France

11. Institut National de la Santé et de la Recherche Médicale (INSERM); U1015; Equipe Labellisée Ligue Nationale Contre le Cancer; Gustave Roussy Cancer Campus; Villejuif France

12. Unit of Tumor Immunology and Immunotherapy; Department of Research, Advanced Diagnostics and Technological Innovation; Regina Elena National Cancer Institute; Rome Italy

13. Department of Immunohematology and Blood Transfusion; Leiden University; Leiden The Netherlands

14. Medical Center; Leiden The Netherlands

15. Bioinformatic Core Facility; UMS AMMICA; INSERM US23; CNRS UMS3665; Gustave Roussy; Villejuif France

16. Immatics US; Houston TX USA

17. Immatics Biotechnologies; Tübingen Germany

18. Department of Immunology; Institute for Cell Biology; University of Tübingen; Tübingen Germany

19. ISA Pharmaceuticals; Leiden The Netherlands

20. Department of Chemistry; Faculty of Arts and Sciences; Université de Montréal; Montreal Quebec Canada

21. Division of Hematology; Hôpital Maisonneuve-Rosemont; Montreal Quebec Canada

22. Metabolomics and Cell Biology Platforms; Gustave Roussy Cancer Campus; Villejuif France. Pôle de Biologie; Hôpital Européen Georges Pompidou; AP-HP; Paris France. Department of Women's and Children's Health; Karolinska University Hospital; Stockholm Sweden

Funder

Institut Universitaire de France

Ligue Contre le Cancer

Agence Nationale de la Recherche

Cancéropôle Ile-de-France

Fondation pour la Recherche Médicale

Institut National Du Cancer

LabEx Immuno-Oncology

LeDucq Foundation

Associazione Italiana per la Ricerca contro il Cancro

Ministero Italiano della Salute

Paris Alliance of Cancer Research Institutes (PACRI)